MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis
Jeffrey B. Kopp(National Institute of Diabetes and Digestive and Kidney Diseases), Michael W. Smith(Science Applications International Corporation (United States)), George W. Nelson(National Cancer Institute), Randall C. Johnson(National Cancer Institute), Barry I. Freedman(Wake Forest University), Donald W. Bowden(Wake Forest University), Tarás K. Oleksyk(Science Applications International Corporation (United States)), Louise M. McKenzie(Science Applications International Corporation (United States)), Hiroshi Kajiyama(National Institute of Diabetes and Digestive and Kidney Diseases), Tejinder S. Ahuja(The University of Texas Medical Branch at Galveston), Jeffrey S. Berns(University of Pennsylvania), W Briggs(Beaumont Hospital, Royal Oak), Monique E. Cho(National Institutes of Health), Richard A. Dart(Marshfield Clinic), Paul L. Kimmel(George Washington University), Stephen M. Korbet(Rush University Medical Center), Donna M. Michel(Kidney Associates), Michele H. Mokrzycki(Albert Einstein College of Medicine), Jeffrey R. Schelling(Case Western Reserve University), Eric E. Simon(Tulane University), Howard Trachtman(Schneider Children's Hospital), David Vlahov(New York Academy of Medicine), Cheryl A. Winkler(Science Applications International Corporation (United States))
Cited by 705
Abstract
Related Papers
No related papers found
Powered by citation graph analysis